Conforma Therapeutics' Series C Round

Conforma Therapeutics raised a round of funding on May 06, 2005.

Conforma Therapeutics is focused on the design and development of novel drugs for the selective treatment of cancer. Conforma developed drugs that target the cellular HSP90 family of molecular "chaper…

Articles about Conforma Therapeutics' Series C Round: